SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wang David H

(Last)(First)(Middle)
C/O ACM RESEARCH, INC.
42307 OSGOOD ROAD, SUITE I

(Street)
FREMONT CALIFORNIA 94539

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ACM Research, Inc. [ ACMR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/03/2026M60,000A$1862,708D
Class A Common Stock06/03/2026S(1)4,300D$87.57(2)858,408D
Class A Common Stock06/03/2026S(1)6,295D$88.98(3)852,113D
Class A Common Stock06/03/2026S(1)32,450D$89.84(4)819,663D
Class A Common Stock06/03/2026S(1)9,925D$90.78(5)809,738D
Class A Common Stock06/03/2026S(1)5,843D$92.38(6)803,895D
Class A Common Stock06/03/2026S(1)1,187D$93.04(7)802,708D
Class A Common Stock06/04/2026M40,002A$1842,710D
Class A Common Stock06/04/2026S(1)2,060D$83.86(8)840,650D
Class A Common Stock06/04/2026S(1)17,543D$85.11(9)823,107D
Class A Common Stock06/04/2026S(1)10,992D$86.07(10)812,115D
Class A Common Stock06/04/2026S(1)8,581D$87.13(11)803,534D
Class A Common Stock06/04/2026S(1)826D$87.91(12)802,708D
Class A Common Stock100,002IBy Jing Chen, wife of David H. Wang
Class A Common Stock45,837IBy Sophia Wang, daughter of David H. Wang
Class A Common Stock180,000IBy David Hui Wang and Jing Chen Family Irrevocable Trust for Wang Children
Class A Common Stock620,001IBy Wang-Chen Family Living Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option$106/03/2026M60,000 (13)12/27/2026Class A Common Stock60,000$0310,002D
Stock Option$106/04/2026M40,002 (13)12/27/2026Class A Common Stock40,002$0270,000D
Explanation of Responses:
1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.22 to $88.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), and (12) to this Form 4.
3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.24 to $89.22, inclusive.
4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.24 to $90.22, inclusive.
5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.24 to $91.22, inclusive.
6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.01 to $92.8, inclusive.
7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $93.02 to $93.39, inclusive.
8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $83.61 to $84.24, inclusive.
9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $84.62 to $85.6, inclusive.
10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.7 to $86.57, inclusive.
11. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.73 to $87.66, inclusive.
12. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.77 to $88.01, inclusive.
13. The option is fully vested and exercisable.
Remarks:
Chief Executive Officer, President and Director
/s/ Mark McKechnie, Attorney-in-Fact for David H. Wang06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)